Ticker Details
Cel-Sci Corporation CEL-SCI Corp is a biotechnology company. It is engaged in the research and development directed at improving the treatment of cancer and other diseases by utilizing the immune system, the body's natural defense system.
IPO Date:	December 1, 1984
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$40.36M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.20 | 4.96%
Avg Daily Range (30 D):	$0.25 | 4.54%
Avg Daily Range (90 D):	$0.27 | 4.34%

Institutional Daily Volume
Avg Daily Volume:	.16M
Avg Daily Volume (30 D):	.06M
Avg Daily Volume (90 D):	.07M

Trade Size
Avg Trade Size (Sh.):	87
Avg Trade Size (Sh.) (30 D):	126
Avg Trade Size (Sh.) (90 D):	141

Institutional Trades
Total Institutional Trades:	351
Avg Institutional Trade:	$1.44M
Avg Institutional Trade (30 D):	$1.32M
Avg Institutional Trade (90 D):	$1.32M
Avg Institutional Trade Volume:	M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.59M
Avg Closing Trade (30 D):	$1.32M
Avg Closing Trade (90 D):	$1.32M
Avg Closing Volume:	5.66K

News

Nov 4, 2024 @ 8:52 PM 3 Interesting Emerging Growth Stock Ideas From the... Source: Professor Ari Zoldan

Dec 4, 2023 @ 6:10 PM Why U Power Shares Are Trading Lower By Around 54%... Source: Lisa Levin

Jul 18, 2023 @ 5:00 PM Why Lixte Biotechnology Shares Are Trading Lower B... Source: Lisa Levin

Jul 18, 2023 @ 1:51 PM US Stocks Mixed; Bank of America Tops Q2 Views Source: Lisa Levin

Jul 18, 2023 @ 12:12 PM Why Biophytis Shares Are Trading Higher By 54%; He... Source: Lisa Levin

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS
Diluted EPS	$-2.05	$-.68	$.07
Revenue	$-.57M	$-.09M	$-.13M
Gross Profit
Net Income / Loss	$37.95M	$5.47M	$44.72M
Operating Income / Loss	$-23.29M	$-5.37M	$-6.03M
Cost of Revenue
Net Cash Flow	$6.34M	$M	$9.16M
PE Ratio

Splits
May 20, 2025	1:30
Jun 15, 2017	1:25
Sep 25, 2013	1:10